concentration of Con A for the experiment was determined as follows. 0-2 ml heat inactivated and absorbed rheumatoid sera were added to 0-8 ml of solutions containing various amounts of Con A and incubated at 37°C for 60 minutes. After centrifugation at 3000 r.p.m. for 10 minutes, precipitates were removed and 1-0 ml of 0 3 mol/l methyl-a-D-glucoside was added to each supernatant to neutralize the activity of Con A. Neutralization was confirmed by the disappearance of agglutinating activity of Con A against both sheep and human red cells.
Levels of IgG, IgA, and IgM in Con A-treated sera were measured by single radial immunodiffusion as described by Mancini, Carbonara, and Heremans (1965) using Partigen Immunoplates (Behring Institute, Germany). Optimal concentration of Con A was chosen at the point of maximal decreased IgM level and minimal decreased IgG level.
MEASUREMENT OF RF ACTIVITY
After Con A treatment with the optimal concentration, RF activity of each serum was measured with LFT (RA-test, Hyland, Calif.) and with SSCA. For SSCA, sheep red cells (SRC) were sensitized with four times dilution of minimal agglutination dose of IgG rabbit anti-SRC (IgG haemolysin) and haemagglutination procedure was performed with Micro-Titer (Cooke Engineering Co., Va.). 7S fractions of rabbit anti-SRC serum were separated by Sephadex G 200 gel filtration and used as IgG haemolysin. Gelatin veronal buffer (GVB, pH 7 4) containing 0-15 mol/l methyl-a-D-glucoside was used as the reaction buffer.
MEASUREMENT OF COMPLEMENT FIXING ABILITY OF RF
Complement-fixing ability of IgM-and IgG-RF was evaluated in the direct haemolytic test as described previously (Tanimoto and others, 1975) . Rabbit IgG haemolysin was reduced with 0-01 mol/l dithiothreitol at room temperature for 30 minutes and alkylated with 0-015 mol/l iodacetamide at 0°C for 120 minutes. Reduced and alkylated IgG haemolysin loses complement fixing ability while retaining antigen binding activity and reactivity to RF (Tanimoto and others, 1975) . SRC sensitized with the reduced and alkylated IgG haemolysin were prepared in the same way as the nonreduced IgG haemolysin described above. The sensitized SRC were incubated with Con A treated or nontreated rheumatoid sera at 37°C for 60 minutes and at 0°C for 180 minutes. The reaction between the sensitized SRC and RF was macroscopically observed as haemagglutination.
SRC treated with the above method were washed three times with 0-15 mol/l gelatin veronal buffer pH 7-4, containing optimal amounts of Ca++ and Mg++ (GVB++). Excess Con A and methyl-a-D-glucoside were removed during this procedure. The cells suspended in GVB++ were added to diluted human complement in which natural antibody to SRC had been absorbed in advance.
Haemolysis of the sensitized SRC by rheumatoid factor occurred after incubation at 37°C for 60 minutes with human complement. Complement fixing ability of RF was estimated by the measurement of haemoglobin concentration in the supernatant at 412 mp on Hitachi's spectrophotometer as per cent haemolysis.
MEASUREMENT OF SERUM COMPLEMENT LEVELS
Serum complement levels were determined by Mayer's 50 % haemolytic method (CHfo) (Mayer, 1961) using SRC sensitized with rabbit IgM haemolysin.
Results
As shown in Fig. 1 The results of complement fixing ability of rheuma-sera. Haemolytic activities before Con A treatment (0) toid sera before and after Con A treatment are and after Con A treatment (0) (Leon, 1967; Goldstein and others, 1969 ; Weinstein es (% haemolysis) before Con A treat-and others, 1972), while in our study 60% of IgA A treatment was removed. Such contamination of IgA also occurred in pepsin digestion of serum for the detection tciated RF levels are determined of IgG-RF (Theofi!opoulos and others, 1974).
immunoglobulin class. However, the influence of contaminated IgN will tion technique (Adachi and others, be negligible for the estimation of complement in be evaluated by the augmentation fixation because IgA antibody cannot activate ation, when rabbit antihuman IgG complement via the classical pathway or haemolyse lo the test system using SRC sensi-the red cells. IgG.
For the detection of IgG-RF, methods other than estion of IgM (Theofilopoulos and LFT or SSCA should be considered since agglutinSince pepsin-treated serum loses ating activities of IgG-RF are not so strong as those ivity of IgM-RF, weak agglutinating of IgM-RF. Authors tried to use reversed immuno-F in the treated serum can be found diffusion in agarose containing aggregated human ;glutination tests.
IgG as described by Theofilopoulos and others iorescent method (Estes, Atra, and (1974) for the detection of IgG-RF after Con A treatFluorescein isothiocyanate (FITC) ment. However, sharp precipitin rings did not appear itihuman IgG serum stains IgG-RF in the plate, and we have considered that this method man red cells sensitized with rabbit would not be appropriate for the quantitation of 111 serum.
IgG-RF. When LFT was compared with SSCA for )adsorbent method RF dissociated sensitivity in the detection of IgG-RF, LFT showed a aggregated IgG in acid may lose higher incidence of positive results than SSCA. This since acid has the ability to destroy result confirmed the report by Theofilopoulos and le. When the levels of IgG and IgA others (1974). ovith single radial immunodiffusion A few cases exhibited increased RF activities after I,the reported values were consider-Con A treatment, the exact cause of which is not Ln expected (Panush and others, clear (Panush and others, 1971; Bianco and others, 1971) , and sera with high titre RF sometimes showed prozone phenomenon (Harboe, 1960) . These findings may have some bearing on our results. Further investigations are in progress in order to clarify the mechanism of the raised RF activity after Con A treatment.
The results of the present study indicate that IgG-RF has weak complement-fixing ability which correlated with its agglutination activity. It was already proved that the direct haemolytic method used in this study is sensitive for the estimation of complement fixation with IgM-RF (Tanimoto and others, 1975) . It is conceivable that this method is also sensitive with IgG-RF.
The finding that IgG-RF is able to fix complement suggests that IgG-RF could play a role in the inflammatory process in RA through complement activation. In fact, some synovial fluids of patients with RA show anticomplementary activities (Marcus and Townes, 1971 ;  Townes and Marcus, 1972) and in these cases immune complexes mainly consist of IgG-RF rather than IgM-RF (Winchester, Agnello, and Kunkel, 1969, 1970 (Hannestad, 1967; Winchester and others, 1969; Marcus and Townes, 1971; Munthe and Natvig, 1971; Mellbye and Natvig, 1971; Townes and Marcus, 1972 
